A look at the Green Pharma Summit

The Green Pharma Sumit LinkedIn newsletter came out this week. Click here to read it. If you haven't joined our LinkedIn Green Pharma Summit Group, join today. You'll receive more updates and network with others who strive to make Pharma a more sustainable and eco-friendly industry.

If you were unable to attend the Green Pharma Summit, we have notes on the discussions during event’s roundtables, networking breaks and panels focusing on Pharma’s opportunities, challenges and actions going forwards. See what they discussed here:
http://bit.ly/GPPres

Share this article with your social network, just click below to share now!

Share |

Follow Biosimilars on Twitter!

Biosimilars now has a Twitter and LinkedIn Group!

Follow us on Twitter: http://twitter.com/biosimilars
Join Us on LinkedIn: http://www.linkedin.com/groups?gid=1854917

Share this article with your social network, just click below to share now!

Share |

Biosimilars Bill Offers New Hope

This post on Pharmafocus discusses that the US has gotten a step closer to being able to market generic verions of biologic drugs in the USA for the first time, if the Pathway for Biosimilars Act is passed. Europe has seen a similar legislation pass in 2003, but now the Obama administration seems determined to bring biosimilars here in the US to reduce on healthcare costs. There is much skepticism though as many people say that biosimilars do not behave the same way as originator drugs when it comes to safety and efficacy. What is your take?

If you’re interested in connecting with other professionals in the Biosimilars field, join us at LinkedIn.

Share this article with your social network, just click below to share now!

Share |